Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

SAPIEN 3 TAVR Durability

Presenter: Karim Al-Azizi

June 09, 2023

Presentation TVT 2023

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Presenter: Danny Dvir

June 08, 2023

Presentation TVT 2022

Matching Valve Durability with Life Expectancy after AVR:

Presenter: James Harvey

June 09, 2022

Presentation TVT 2022

Durability Matters: Results of the High Risk-SURTAVI 5 year outcomes.

Presenter: Joshua Rovin

June 09, 2022

Presentation TVT 2022

Leaflet Durability and Thrombogenicity in TMVR Devices: The Elephant in the Room

Presenter: Steven Yakubov

June 09, 2022

Presentation TVT 2022

Massive Annular Dilatation: Implications for Repair Durability and Valve Sizing

Presenter: Robert Smith

June 08, 2022

Presentation TVT 2021

Predictions on Late Trans-Catheter Mitral Failure Modes: Management Strategies and Innovation Opportunities

Presenter: Nicolo Piazza

July 21, 2021

Presentation TVT 2021

Predictions on Late TAVR Failure Modes: Management Strategies and Innovation Opportunities

Presenter: Tsuyoshi Kaneko

July 21, 2021

Presentation TVT 2021

Management of Failed TAVR Bioprostheses: TAV-in-TAV and Surgical TAVR Explanation

Presenter: Tsuyoshi Kaneko

July 20, 2021

Presentation TVT 2021

Synthesizing the Valve Leaflet Thickening CT Sub-studies: Implications for Anti-Thrombotic Therapy and Indications for Post-TAVR CT-Imaging

Presenter: Raj Makkar

July 20, 2021

Presentation TVT 2021

Summarizing the New VARC 3 Consensus Definitions of Hemodynamic Valve Deterioration and Bioprosthetic Valve Failure

Presenter: Rebecca Hahn

July 20, 2021

Presentation TVT 2021

Shared Decision Making for the Management of the TAVR Patient

Presenter: Megan Coylewright

July 20, 2021

Presentation TVT 2021

Considerations for Index Valve Implantation

Presenter: Guilherme F. Attizzani

July 20, 2021

Presentation TVT 2021

Predictors of Hemodynamic Valve Deterioration

Presenter: Daniel O'Hair

July 20, 2021

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

Presentation TVT 2019

Valve Performance and Durability After Transcatheter Versus Surgical Aortic Valve Replacement — A Meta-Analysis of Randomized Controlled Trials

Presenter: Ankur Sethi

June 14, 2019

Presentation TVT 2019

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Presenter: John Webb

June 13, 2019

Advertisement

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

SAPIEN 3 TAVR Durability

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Matching Valve Durability with Life Expectancy after AVR:

Durability Matters: Results of the High Risk-SURTAVI 5 year outcomes.

Leaflet Durability and Thrombogenicity in TMVR Devices: The Elephant in the Room

Massive Annular Dilatation: Implications for Repair Durability and Valve Sizing

Predictions on Late Trans-Catheter Mitral Failure Modes: Management Strategies and Innovation Opportunities

Predictions on Late TAVR Failure Modes: Management Strategies and Innovation Opportunities

Management of Failed TAVR Bioprostheses: TAV-in-TAV and Surgical TAVR Explanation

Synthesizing the Valve Leaflet Thickening CT Sub-studies: Implications for Anti-Thrombotic Therapy and Indications for Post-TAVR CT-Imaging

Summarizing the New VARC 3 Consensus Definitions of Hemodynamic Valve Deterioration and Bioprosthetic Valve Failure

Shared Decision Making for the Management of the TAVR Patient

Considerations for Index Valve Implantation

Predictors of Hemodynamic Valve Deterioration

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Valve Performance and Durability After Transcatheter Versus Surgical Aortic Valve Replacement — A Meta-Analysis of Randomized Controlled Trials

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content